- History - 11:01
Taiwanese president praises new fellowship fund at University of Michigan - Medicine - 11:00
Insertable Robot Offers New Approach to Minimally Invasive Surgery - Computer Science - 10:00
Is that smile real or fake? - Literature - May 24
UChicago to honor historian Black, theater director Bogart at Convocation - Agronomy - May 24
Diagnostic labs analyze anything from bugs to toenails - Medicine - May 24
UCLA launches first face transplantation program in western U.S - Administration - May 24
’Click It or Ticket’ Enforcement on Penn Campus - Medicine - May 24
Hormone Plays Surprise Role in Fighting Skin Infections - Pedagogy - May 24
Two SEAS profs envision the next big ideas in teaching and learning - Environmental Sciences - May 24
Columbia's Manhattanville Campus Earns LEED Platinum for Neighborhood Plan - Literature - May 24
Historic Greek Theatre safe, sound and superb after upgrades - Law - May 24
Latest UT/Texas Tribune Poll: Tax Pledge Issue Reveals Conservative Divide
Administration
Chemistry
Physics
Computer Science
Environmental Sciences
Earth Sciences
Life Sciences
Medicine
Business
Law
Literature
History
Arts
» » more
Statins may protect against death from aneurysm, Yale study finds
A study by Yale School of Medicine reveals that survival rates for patients with a thoracic aneurysm are significantly better, and complications are fewer, among patients who take statin cholesterol drugs than those who do not. The study appears in the American Journal of Cardiology.
An aneurysm is a swelling of an artery, and is a common cause of death. It’s usually asymptomatic, with death or a life-threatening complication such as rupture or dissection being the first manifestation. Statins are cholesterol-lowering drugs that are widely used in patients with cardiovascular disease.
Assistant professor of cardiothoracic surgery Ion S. Jovin, M.D., and colleagues studied 649 patients with thoracic aortic aneurysms: 147 were taking statins and 502 were not. In long-term follow-up 80% of those taking statins survived, compared with 67% percent of those not taking statins. In addition, a smaller percentage of those taking statins suffered a rupture or dissection (splitting of the aorta), compared to those who were not taking statins.
"The intake of statins was associated with an improvement in long-term outcomes among these patients," said co-author John Elefteriades, M.D., professor of cardiothoracic surgery at Yale School of Medicine and director of the Aortic Institute at Yale-New Haven Hospital. "In addition to better survival, fewer patients taking statins required surgical intervention," Elefteriades added.
Medical science has searched for decades for a medicine that could treat aneurysm disease, with little success. The current standard therapy is to keep blood pressure low to discourage rupture of the enlarged artery. Jovin said his research suggests that "statins could offer a significant protective effect to patients at risk of death or complications from aneurysm disease. However, the ultimate proof would be a randomized clinical trial." Elefteriades adds, "We now have some arrows in our quiver of medicines to treat this disease."
Other authors are Mona Duggal, Keita Ebisu, Hyung Paek, A. Dana Oprea, Maryann Tranquilli, John Rizzo, Redin Memet, Marina Feldman, James Dziura, and Cynthia A. Brandt of Yale.
Links
Yale UniversityLast job offers
- Law - 21.5
Doctoral Programme at the Law School of the University of Basel - Life Sciences - 18.4
Senior Expert - Genetic Biomarker Oncology (PhD) m/f - Business - 22.5
Research Associate - Life Sciences - 15.5
Staff Research Associate II - Civil Engineering - 15.5
Research Specialist - Beckman Institute (A1200274) - Medicine - 12.5
Research Specialist - Business - 4.5
Assistant Professor of Economics, Non Tenure Track, Fall 2012 - Business - 3.5
Post Doctoral Fellow

» Share this page: